Sam Forshaw

MSc by research 2015-2016. Recently completed and passed his MSc.

PhD student from October 2017-Sept 2021, on strained alkynes and in collaboration with AstraZeneca. Sam has recently (early 2022) successfully completed his PhD and is now working at Sygnature.